67.00
2.98%
-2.06
시간 외 거래:
67.10
0.10
+0.15%
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Massachusetts Financial Services Co. MA Invests $12.34 Million in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
MarketBeat
3 Monster Stocks in the Making You Can Buy Right Now
The Motley Fool
Viking Therapeutics (NASDAQ:VKTX) Upgraded at Raymond James - Defense World
Defense World
Viking Therapeutics (NASDAQ:VKTX) Stock Rating Upgraded by StockNews.com - MarketBeat
MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Upgraded to Sell at StockNews.com - Defense World
Defense World
Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next? - InvestorPlace
InvestorPlace
Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next? - InvestorPlace
InvestorPlace
Emerging Leaders: Roche, Viking Therapeutics In The Obesity Treatment Race (OTCMKTS:RHHBY) - Seeking Alpha
Seeking Alpha
Smart Money Is Betting Big In VKTX Options - Viking Therapeutics (NASDAQ:VKTX) - Benzinga
Benzinga
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Zacks Investment Research
Is Viking Therapeutics Stock a Buy?
The Motley Fool
MSN - MSN
MSN
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates - MSN
MSN
Viking Therapeutics posts positive results for oral weight-loss drug. Analysts remain unanimous the stock's a buy. - MSN
MSN
Viking Therapeutics (NASDAQ:VKTX) Upgraded to Strong-Buy at Raymond James - MarketBeat
MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Gap Down to $78.01 - MarketBeat
MarketBeat
Truist maintains $120 target on Viking Therapeutics stock By Investing.com - Investing.com
Investing.com
Viking stock falls after Roche's obesity data (NASDAQ:VKTX) - Seeking Alpha
Seeking Alpha
Viking stock falls after Roche's obesity data (NASDAQ:VKTX) - Seeking Alpha
Seeking Alpha
Viking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at Truist Financial - MarketBeat
MarketBeat
Viking stock falls after Roche obesity data (NASDAQ:VKTX) - Seeking Alpha
Seeking Alpha
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio? - MSN
MSN
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today By Benzinga - Investing.com UK
Investing.com UK
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio? - Yahoo Finance
Yahoo Finance
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio? - Zacks Investment Research
Zacks Investment Research
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks Investment Research
How Is The Market Feeling About Viking Therapeutics? - Viking Therapeutics (NASDAQ:VKTX) - Benzinga
Benzinga
Is Viking Therapeutics the Best Biotech Stock for You? - MSN
MSN
Viking Therapeutics (NASDAQ:VKTX) Shares Down 3.4% - MarketBeat
MarketBeat
How Viking Therapeutics Stock Could 30x - Yahoo Finance
Yahoo Finance
Is Viking Therapeutics the Best Biotech Stock for You? - AOL
AOL
What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner (VKTX) - Seeking Alpha
Seeking Alpha
Russell Investments Group Ltd. Purchases Shares of 256,633 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
MarketBeat
How Much Are Viking Therapeutics, Inc. (NASDAQ:VKTX) Insiders Spending On Buying Shares? - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired (NASDAQ:VKTX) - Seeking Alpha
Seeking Alpha
Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired (NASDAQ:VKTX) - Seeking Alpha
Seeking Alpha
Viking Therapeutics's Options Frenzy: What You Need to Know - Viking Therapeutics (NASDAQ:VKTX) - Benzinga
Benzinga
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks Investment Research
We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth - Yahoo News UK
Yahoo News UK
Viking Therapeutics's Options Frenzy: What You Need to Know - Viking Therapeutics (NASDAQ:VKTX) - Benzinga
Benzinga
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data - The Globe and Mail
The Globe and Mail
Analysts Set Viking Therapeutics, Inc. (NASDAQ:VKTX) Target Price at $112.25 - Defense World
Defense World
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
The Motley Fool
Viking Therapeutics CFO sells over $4.9 million in company stock - Investing.com
Investing.com
Viking Therapeutics Delivers Smaller-Than-Expected Q1 Loss - The Motley Fool
The Motley Fool
Is Viking Therapeutics Incredibly Undervalued?
The Motley Fool
Can This High-Flying Stock 10x in 10 Years?
The Motley Fool
1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst
The Motley Fool
Is Viking Therapeutics Incredibly Undervalued? - Nasdaq
Nasdaq
We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth - Simply Wall St
Simply Wall St
자본화:
|
볼륨(24시간):